// App-Quantinova.ai

EP930 : QUANTIFYING THE HEALTHCARE RESOURCE USE AND CLINICAL OUTCOMES OF PATIENTS WITH MYELODYSPLASTIC SYNDROME WITH RINGED SIDEROBLASTS IN ENGLAND

Researchers

Presenter

  • James Farrell

Principal Investigators

  • Archie Farrer

  • Louise Maher

  • Manoj Chevli

Medical Centers

  • IMS Health, London, United Kingdom

  • Bristol-Myers Squibb, Uxbridge, United Kingdom

  • Bristol-Myers Squibb, Uxbridge, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Alpha-thalassemia myelodysplasia syndrome

Biomarkers

  • Tyrosine 3-Monooxygenase/Tryptophan 5-Monooxygenase Activation Protein Epsilon

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved